GT BIOPHARMA, INC. (GTBP) Total liabilities 2016–2020
GT BIOPHARMA, INC. (GTBP) total liabilities at each fiscal year-end, per SEC filings.
$35.1MFY2020 · since FY2016: $18.9M → $35.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $35.1M | +78.1% |
| FY2019 | $19.7M | — |
| FY2017 | $2.7M | -85.9% |
| FY2016 | $18.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice